They have the ability to assess the activity of analgesics under development in both simple models of chemical sensitisation (such as capsaicin-induced allodynia) and complex models representative of disease states where there is a high demand for new analgesics, including models of neuropathic pain (such as antineoplastic-induced neuropathy) or rheumatoid arthritis (among many others).